(CDP) COPT Defense Properties - Overview
Stock: Office, Warehouse, Data, Secure, Proximate
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.38% |
| Yield on Cost 5y | 5.61% |
| Yield CAGR 5y | 2.62% |
| Payout Consistency | 95.3% |
| Payout Ratio | 122.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 18.5% |
| Relative Tail Risk | -2.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.56 |
| Alpha | 7.40 |
| Character TTM | |
|---|---|
| Beta | 0.401 |
| Beta Downside | 0.399 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.66% |
| CAGR/Max DD | 0.52 |
Description: CDP COPT Defense Properties January 12, 2026
COPT Defense Properties (NYSE: CDP) is an S&P MidCap 400 REIT that self-manages a portfolio of 198 properties-22.6 million sq ft-located near or within U.S. government defense installations. As of 30 Sept 2025 the portfolio was 97 % leased, with tenants comprising the U.S. government and its defense contractors who demand mission-critical, high-security space.
Key industry metrics that shape CDP’s outlook include: (1) FY 2024 funds-from-operations (FFO) grew 8 % year-over-year, driven by rising lease rates and limited new supply in the defense-site niche; (2) the U.S. defense budget is projected to increase ~3 % annually through 2028, supporting demand for secure real estate; and (3) REITs with similar exposure have maintained average cap rates near 5.5 % despite a 0.75 % rise in 10-year Treasury yields, indicating relative pricing resilience.
For a deeper dive into CDP’s valuation metrics, you might explore ValueRay’s analyst tools.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 149.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.92 > 1.0 |
| NWC/Revenue: 24.70% < 20% (prev 32.60%; Δ -7.89% < -1%) |
| CFO/TA 0.08 > 3% & CFO 351.6m > Net Income 149.9m |
| Net Debt (2.47b) to EBITDA (391.1m): 6.31 < 3 |
| Current Ratio: 1.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (113.2m) vs 12m ago 0.16% < -2% |
| Gross Margin: 52.10% > 18% (prev 0.34%; Δ 5176 % > 0.5%) |
| Asset Turnover: 17.47% > 50% (prev 17.70%; Δ -0.23% > 0%) |
| Interest Coverage Ratio: 2.75 > 6 (EBITDA TTM 391.1m / Interest Expense TTM 84.3m) |
Altman Z'' -0.48
| A: 0.04 (Total Current Assets 393.3m - Total Current Liabilities 208.0m) / Total Assets 4.35b |
| B: -0.23 (Retained Earnings -991.9m / Total Assets 4.35b) |
| C: 0.05 (EBIT TTM 232.2m / Avg Total Assets 4.29b) |
| D: -0.36 (Book Value of Equity -990.8m / Total Liabilities 2.77b) |
| Altman-Z'' Score: -0.48 = B |
Beneish M -3.36
| DSRI: 1.03 (Receivables 292.5m/285.0m, Revenue 750.0m/749.6m) |
| GMI: 0.65 (GM 52.10% / 34.08%) |
| AQI: 1.01 (AQ_t 0.90 / AQ_t-1 0.89) |
| SGI: 1.00 (Revenue 750.0m / 749.6m) |
| TATA: -0.05 (NI 149.9m - CFO 351.6m) / TA 4.35b) |
| Beneish M-Score: -3.36 (Cap -4..+1) = AA |
What is the price of CDP shares?
Over the past week, the price has changed by +5.32%, over one month by +14.66%, over three months by +13.55% and over the past year by +14.02%.
Is CDP a buy, sell or hold?
- StrongBuy: 5
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CDP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.1 | 2.1% |
| Analysts Target Price | 33.1 | 2.1% |
| ValueRay Target Price | 36.4 | 12% |
CDP Fundamental Data Overview February 07, 2026
P/S = 4.9148
P/B = 2.3363
Revenue TTM = 750.0m USD
EBIT TTM = 232.2m USD
EBITDA TTM = 391.1m USD
Long Term Debt = 2.44b USD (from longTermDebt, last quarter)
Short Term Debt = 481.0k USD (from shortTermDebt, last quarter)
Debt = 2.49b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.47b USD (from netDebt column, last quarter)
Enterprise Value = 6.17b USD (3.70b + Debt 2.49b - CCE 23.7m)
Interest Coverage Ratio = 2.75 (Ebit TTM 232.2m / Interest Expense TTM 84.3m)
EV/FCF = 19.79x (Enterprise Value 6.17b / FCF TTM 311.6m)
FCF Yield = 5.05% (FCF TTM 311.6m / Enterprise Value 6.17b)
FCF Margin = 41.55% (FCF TTM 311.6m / Revenue TTM 750.0m)
Net Margin = 19.99% (Net Income TTM 149.9m / Revenue TTM 750.0m)
Gross Margin = 52.10% ((Revenue TTM 750.0m - Cost of Revenue TTM 359.2m) / Revenue TTM)
Gross Margin QoQ = 98.70% (prev 37.68%)
Tobins Q-Ratio = 1.42 (Enterprise Value 6.17b / Total Assets 4.35b)
Interest Expense / Debt = 0.84% (Interest Expense 20.9m / Debt 2.49b)
Taxrate = 1.44% (612.0k / 42.5m)
NOPAT = 228.8m (EBIT 232.2m * (1 - 1.44%))
Current Ratio = 1.89 (Total Current Assets 393.3m / Total Current Liabilities 208.0m)
Debt / Equity = 1.65 (Debt 2.49b / totalStockholderEquity, last quarter 1.51b)
Debt / EBITDA = 6.31 (Net Debt 2.47b / EBITDA 391.1m)
Debt / FCF = 7.92 (Net Debt 2.47b / FCF TTM 311.6m)
Total Stockholder Equity = 1.50b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.49% (Net Income 149.9m / Total Assets 4.35b)
RoE = 10.01% (Net Income TTM 149.9m / Total Stockholder Equity 1.50b)
RoCE = 5.89% (EBIT 232.2m / Capital Employed (Equity 1.50b + L.T.Debt 2.44b))
RoIC = 5.86% (NOPAT 228.8m / Invested Capital 3.91b)
WACC = 4.75% (E(3.70b)/V(6.19b) * Re(7.39%) + D(2.49b)/V(6.19b) * Rd(0.84%) * (1-Tc(0.01)))
Discount Rate = 7.39% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.25%
[DCF Debug] Terminal Value 87.03% ; FCFF base≈275.8m ; Y1≈296.7m ; Y5≈363.5m
Fair Price DCF = 73.22 (EV 10.76b - Net Debt 2.47b = Equity 8.29b / Shares 113.2m; r=5.90% [WACC]; 5y FCF grow 8.53% → 2.90% )
EPS Correlation: 2.40 | EPS CAGR: 32.88% | SUE: 0.02 | # QB: 0
Revenue Correlation: 42.44 | Revenue CAGR: 3.88% | SUE: 0.14 | # QB: 0
EPS next Year (2026-12-31): EPS=1.32 | Chg30d=-0.030 | Revisions Net=-1 | Growth EPS=+4.2% | Growth Revenue=+4.3%